Literature DB >> 10773355

Celiac disease and TNF promoter polymorphisms.

E G de la Concha1, M Fernández-Arquero, P Vigil, A Rubio, C Maluenda, I Polanco, C Fernandez, M A Figueredo.   

Abstract

The possibility that genetic susceptibility to celiac disease (CD) might be influenced by tumor necrosis factor (TNF) genes polymorphism has repeatedly been put forward. To date, this has only been investigated in case-control studies and results have been contradictory. In order to avoid any possible ethnic mismatching between patients and controls, we have approached this problem studying 71 celiac families, establishing the parental haplotypes and comparing CD versus control haplotypes (the so-called AFBAC or affected family-based controls). We used DNA-based methods to screen for HLA-DRB1, -DQA1, and -DQB1 alleles, TNFalpha promoter polymorphims and TNFa and b microsatellites. The guanine-to-adenine polymorphism at position -308 of the TNFalpha gene promoter region was found associated with CD as the TNF-308A allele appeared significantly increased in frequency in CD haplotypes, and this was shown to be independent of the association between CD and the DRB1*0301,DQA1*0501,DQB1*0201 alleles. Our results indicate that at least another gene, in addition to the known association of CD with HLA class II, has a susceptibility role in this disease. This should be either TNFalpha or another polymorphic gene in the telomeric end of the HLA class III region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773355     DOI: 10.1016/s0198-8859(99)00187-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  16 in total

Review 1.  Genetic factors underlying gluten-sensitive enteropathy.

Authors:  A S Peña; C Wijmenga
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

Review 2.  Cutting-edge issues in celiac disease and in gluten intolerance.

Authors:  N Bizzaro; R Tozzoli; D Villalta; M Fabris; E Tonutti
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

3.  Interleukin-10 haplotypes in Celiac Disease in the Spanish population.

Authors:  Concepción Núñez; Diana Alecsandru; Jezabel Varadé; Isabel Polanco; Carlos Maluenda; Miguel Fernández-Arquero; Emilio G de la Concha; Elena Urcelay; Alfonso Martínez
Journal:  BMC Med Genet       Date:  2006-03-31       Impact factor: 2.103

4.  Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.

Authors:  Olga Chemnitzer; Katharina Götzel; Luisa Maurer; Arne Dietrich; Uwe Eichfeld; Orestis Lyros; Boris Jansen-Winkeln; Albrecht Hoffmeister; Ines Gockel; René Thieme
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

5.  Coeliac disease and risk of tuberculosis: a population based cohort study.

Authors:  J F Ludvigsson; J Wahlstrom; J Grunewald; A Ekbom; S M Montgomery
Journal:  Thorax       Date:  2006-10-17       Impact factor: 9.139

Review 6.  Genetics of inflammatory bowel disease: the role of the HLA complex.

Authors:  Tariq Ahmad; Sara-E Marshall; Derek Jewell
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

7.  Coeliac disease in the father affects the newborn.

Authors:  J F Ludvigsson; J Ludvigsson
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

8.  Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles.

Authors:  Andrew S Louka; Benedicte A Lie; Bente Talseth; Henry Ascher; Johan Ek; Audur H Gudjónsdóttir; Ludvig M Sollid
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

9.  Association of -1087 IL10 and -308 TNFA gene polymorphisms with serological markers of coeliac disease.

Authors:  M Hahn-Zoric; A M Hytönen; L A Hanson; L A Nilsson; L Padyukov
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

10.  HLA and celiac disease susceptibility: new genetic factors bring open questions about the HLA influence and gene-dosage effects.

Authors:  Luz María Medrano; Bárbara Dema; Arturo López-Larios; Carlos Maluenda; Andrés Bodas; Natalia López-Palacios; M Ángeles Figueredo; Miguel Fernández-Arquero; Concepción Núñez
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.